Corcept Therapeutics (FRA:HTD) Investments And Advances : €209.9 Mil (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Corcept Therapeutics Investments And Advances?

Corcept Therapeutics's Investments And Advances for the quarter that ended in Dec. 2024 was €209.9 Mil.

Corcept Therapeutics's quarterly Investments And Advances increased from Jun. 2024 (€17.9 Mil) to Sep. 2024 (€150.7 Mil) and increased from Sep. 2024 (€150.7 Mil) to Dec. 2024 (€209.9 Mil).

Corcept Therapeutics's annual Investments And Advances increased from Dec. 2022 (€4.7 Mil) to Dec. 2023 (€52.4 Mil) and increased from Dec. 2023 (€52.4 Mil) to Dec. 2024 (€209.9 Mil).

Corcept Therapeutics Investments And Advances Historical Data

The historical data trend for Corcept Therapeutics's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Investments And Advances Chart

Corcept Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Investments And Advances

Get a 7-Day Free Trial

29.75

99.37

4.67

52.43

209.94

Corcept Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Investments And Advances	Get a 7-Day Free Trial															52.43	37.05	17.94	150.75	209.94

Corcept Therapeutics Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Corcept Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (FRA:HTD) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

CORT:USA 0I3Q:UK HTD:Germany

Address

101 Redwood Shores Parkway, Redwood City, CA, USA, 94065

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.